Q3 2024 |
6 |
$63.6M |
$0 |
-$3.71M |
-$3.71M |
CRSP, CTNM, RPTX, SKYE, ADVM
|
13F-HR |
11/8/2024, 05:18 PM |
Q2 2024 |
8 |
$77.3M |
+$16.2M |
-$1.04M |
+$15.1M |
CRSP, CTNM, SKYE, RPTX, ADVM
|
13F-HR |
8/7/2024, 04:16 PM |
Q1 2024 |
7 |
$103M |
+$31.4M |
-$385M |
-$354M |
CRSP, SKYE, RPTX, GRTS, ADVM
|
13F-HR |
5/3/2024, 04:35 PM |
Q4 2023 |
7 |
$389M |
$0 |
-$275K |
-$275K |
RYZB, CRSP, RPTX, GRTS, PASG
|
13F-HR |
2/8/2024, 05:05 PM |
Q3 2023 |
8 |
$188M |
+$115M |
-$11.2M |
+$103M |
RYZB, RPTX, CRSP, ADVM, GRTS
|
13F-HR |
11/3/2023, 05:10 PM |
Q2 2023 |
8 |
$84.3M |
+$28M |
$0 |
+$28M |
RPTX, CRSP, ADVM, GRTS, CBAY
|
13F-HR |
8/9/2023, 04:55 PM |
Q1 2023 |
7 |
$48M |
$0 |
$0 |
|
CRSP, GRTS, PASG, CBAY, ADVM
|
13F-HR |
5/10/2023, 07:11 PM |
Q4 2022 |
7 |
$48.3M |
$0 |
-$121K |
-$121K |
CRSP, GRTS, PASG, CBAY, ADVM
|
13F-HR |
2/9/2023, 04:13 PM |
Q3 2022 |
8 |
$52.5M |
$0 |
$0 |
|
CRSP, GRTS, ADVM, ALGS, CBAY
|
13F-HR |
11/10/2022, 04:35 PM |
Q2 2022 |
8 |
$65.2M |
$0 |
-$17.8M |
-$17.8M |
CRSP, PASG, GRTS, ADVM, UTRS
|
13F-HR |
8/11/2022, 04:05 PM |
Q1 2022 |
10 |
$100M |
$0 |
$0 |
|
CRSP, PASG, GRTS, CRNX, AKRO
|
13F-HR |
5/10/2022, 04:25 PM |
Q4 2021 |
10 |
$187M |
+$8.6M |
-$29.9M |
-$21.3M |
GRTS, CRSP, PASG, ALGS, AKRO
|
13F-HR |
2/11/2022, 06:05 AM |
Q3 2021 |
11 |
$242M |
$0 |
-$5.92M |
-$5.92M |
CRSP, PASG, GRTS, ALGS, CRNX
|
13F-HR |
11/12/2021, 04:30 PM |
Q2 2021 |
11 |
$302M |
$0 |
-$215M |
-$215M |
CRSP, PASG, ALGS, GRTS, ADVM
|
13F-HR |
8/12/2021, 04:17 PM |
Q1 2021 |
11 |
$513M |
+$87.3M |
-$440M |
-$353M |
CRSP, PASG, ALGS, ADVM, GRTS
|
13F-HR |
5/6/2021, 05:45 PM |
Q4 2020 |
12 |
$963M |
+$297M |
-$130M |
+$167M |
CRSP, NARI, ALGS, ADVM, FLXN
|
13F-HR |
2/16/2021, 07:30 AM |
Q3 2020 |
11 |
$546M |
+$40M |
-$127M |
-$87.3M |
CRSP, ADVM, APRE, FLXN, CRNX
|
13F-HR |
11/12/2020, 05:07 PM |
Q2 2020 |
12 |
$696M |
+$116M |
-$18.5M |
+$97.8M |
CRSP, ADVM, APRE, AKRO, CRNX
|
13F-HR |
7/20/2020, 02:14 PM |
Q1 2020 |
9 |
$365M |
+$127M |
-$3.91M |
+$123M |
CRSP, ADVM, AKRO, VCYT, GRTS
|
13F-HR |
4/28/2020, 12:36 PM |
Q4 2019 |
7 |
$332M |
$0 |
-$17.3M |
-$17.3M |
CRSP, VCYT, GRTS, OCUL, EYES
|
13F-HR |
1/21/2020, 03:12 PM |
Q3 2019 |
8 |
$258M |
$0 |
-$29.6M |
-$29.6M |
CRSP, VCYT, GRTS, BOLD, OCUL
|
13F-HR |
10/8/2019, 02:24 PM |
Q2 2019 |
9 |
$343M |
+$34.6M |
-$48.3M |
-$13.7M |
CRSP, VCYT, GRTS, BOLD, OCUL
|
13F-HR |
7/12/2019, 06:05 AM |
Q1 2019 |
9 |
$304M |
+$22.9M |
-$18.5M |
+$4.32M |
CRSP, VCYT, BOLD, CBAY, OCUL
|
13F-HR |
4/5/2019, 02:25 PM |
Q4 2018 |
10 |
$202M |
$0 |
$0 |
|
CRSP, VCYT, BOLD, OCUL, CBAY
|
13F-HR |
1/22/2019, 04:53 PM |
Q3 2018 |
10 |
$294M |
+$34.9M |
$0 |
+$34.9M |
CRSP, BOLD, VCYT, OCUL, CBAY
|
13F-HR |
10/5/2018, 04:19 PM |
Q2 2018 |
9 |
$321M |
+$182K |
-$58.6M |
-$58.4M |
CRSP, BOLD, OCUL, CBAY, AKAOQ
|
13F-HR |
7/13/2018, 03:40 PM |
Q1 2018 |
8 |
$313M |
+$211M |
$0 |
+$211M |
CRSP, BOLD, AKAOQ, OCUL, CBAY
|
13F-HR |
5/3/2018, 04:43 PM |
Q4 2017 |
7 |
$95M |
$0 |
-$19.6M |
-$19.6M |
BOLD, AKAOQ, OCUL, CBAY, IMDZ
|
13F-HR |
1/25/2018, 02:57 PM |
Q3 2017 |
8 |
$131M |
$0 |
$0 |
|
BOLD, IMDZ, AKAOQ, OCUL, CLVSQ
|
13F-HR |
10/13/2017, 11:52 AM |
Q2 2017 |
8 |
$127M |
$0 |
-$28.6M |
-$28.6M |
BOLD, AKAOQ, IMDZ, OCUL, CLVSQ
|
13F-HR |
8/2/2017, 12:13 PM |
Q1 2017 |
8 |
$138M |
+$8.37M |
-$2.45M |
+$5.92M |
AKAOQ, BOLD, CLVSQ, OCUL, IMDZ
|
13F-HR |
4/7/2017, 01:59 PM |
Q4 2016 |
7 |
$103M |
$0 |
$0 |
|
BOLD, OCUL, CLVSQ, AKAOQ, IMDZ
|
13F-HR |
1/18/2017, 02:47 PM |
Q3 2016 |
7 |
$89.7M |
+$48.9M |
-$94.9M |
-$46M |
BOLD, IMDZ, OCUL, CLVSQ, AKAOQ
|
13F-HR |
10/24/2016, 06:01 AM |
Q2 2016 |
5 |
$98.7M |
$0 |
-$67.5M |
-$67.5M |
GKOS, OCUL, CLVSQ, AKAOQ, CBAY
|
13F-HR |
7/28/2016, 04:21 PM |
Q1 2016 |
7 |
$139M |
$0 |
$0 |
|
GKOS, FPRX, OCUL, CLVSQ, BITI
|
13F-HR |
4/25/2016, 02:10 PM |
Q4 2015 |
7 |
$171M |
$0 |
-$148K |
-$148K |
GKOS, FPRX, OCUL, CLVSQ, AKAOQ
|
Restatement |
5/5/2016, 01:15 PM |
Q3 2015 |
7 |
$174M |
+$107M |
$0 |
+$107M |
GKOS, CLVSQ, OCUL, FPRX, AKAOQ
|
13F-HR |
10/28/2015, 01:33 PM |
Q2 2015 |
5 |
$78.8M |
+$5.37M |
-$44.3M |
-$38.9M |
CLVSQ, FPRX, AKAOQ, BITI, CBAY
|
13F-HR |
7/15/2015, 03:38 PM |
Q1 2015 |
6 |
$114M |
+$4.97M |
$0 |
+$4.97M |
CLVSQ, FPRX, AKAOQ, CBAY, INGN
|
13F-HR |
4/23/2015, 05:01 PM |
Q4 2014 |
5 |
$105M |
$0 |
$0 |
|
CLVSQ, FPRX, AKAOQ, CBAY, KYTH
|
Restatement |
4/23/2015, 04:13 PM |